|
Q2 FY2026
As of Aug 1, 2026
|
Q1 FY2026
As of May 2, 2026
|
Q4 FY2025
As of Jan 31, 2026
|
Q3 FY2025
As of Nov 1, 2025
|
Q2 FY2025
As of Aug 2, 2025
|
Q1 FY2025
As of May 3, 2025
|
Q4 FY2024
As of Feb 1, 2025
|
Q3 FY2024
As of Nov 2, 2024
|
Q2 FY2024
As of Aug 3, 2024
|
Q1 FY2024
As of May 4, 2024
|
Q4 FY2023
As of Feb 3, 2024
|
Q3 FY2023
As of Oct 28, 2023
|
Q2 FY2023
As of Jul 29, 2023
|
Q1 FY2023
As of Apr 29, 2023
|
Q4 FY2022
As of Jan 28, 2023
|
Q3 FY2022
As of Oct 29, 2022
|
Q2 FY2022
As of Jul 30, 2022
|
Q1 FY2022
As of Apr 30, 2022
|
Q4 FY2021
As of Jan 29, 2022
|
Q3 FY2021
As of Oct 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Merchandise inventory | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation | ||||||||||||||||||||
| Operating Lease, Right-of-Use Asset | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Operating Lease, Liability, Current | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term Line of Credit | ||||||||||||||||||||
| Total long-term debt | ||||||||||||||||||||
| Operating Lease, Liability, Noncurrent | ||||||||||||||||||||
| Lease incentives and other long-term liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Common stock, shares outstanding (in shares) | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Authorized 2,300 shares for all periods presented | ||||||||||||||||||||
| Additional Paid in Capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
| Common stock, par value (in dollars per share) |
Loading...
